The pharmacology of tri-potassium di-citrato bismuthate (TDB).
about
Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbitsSusceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate.
P2860
The pharmacology of tri-potassium di-citrato bismuthate (TDB).
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
The pharmacology of tri-potassium di-citrato bismuthate (TDB).
@en
type
label
The pharmacology of tri-potassium di-citrato bismuthate (TDB).
@en
prefLabel
The pharmacology of tri-potassium di-citrato bismuthate (TDB).
@en
P1476
The pharmacology of tri-potassium di-citrato bismuthate (TDB).
@en
P2093
P407
P433
P577
1975-01-01T00:00:00Z